India: Novartis Hearing Postponed To February
The Supreme Court in New Delhi has postponed the Novartis v. Union of India hearing. The case will now be heard on 28 February 2012.
Intellectual Property Watch
Original news and analysis on international IP policy
Category Health & IP
IP, Trade And Public Health Leaders Turn A Page In History Together
The importance of multilateralism, continuing global public health gains with sufficient funding, and finding a balance between the worlds of trade, intellectual property and public health were among the top issues raised during the a daylong high-level meeting at the World Trade Organization.
Doha+10: MSF Asks, What’s Next For TRIPS And Health?
For Médecins Sans Frontières (MSF, or Doctors Without Borders), the 10th anniversary of the Doha Declaration on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and Public Health marks an opportunity to look forward.
WHO Pandemic Advisory Group Adjourns Early
The World Health Organization Pandemic Influenza Preparedness Framework Advisory Group wrapped up its first meeting a day early. Scheduled to meet 21-23 November, the 18-member group was supposed to work out details on how to carry out its mandate, according to sources.
WHO Announces Members Of Pandemic Influenza Advisory Group
The World Health Organization today announced the 18 members of the advisory group that will monitor and report on implementation of the new WHO Pandemic Influenza Preparedness (PIP) Framework. The group started its first meeting today.
10 Years Of TRIPS And Public Health: An Anniversary To Celebrate?
It has been 10 years since the World Trade Organization adopted the Doha Declaration on TRIPS and Public Health. The declaration highlighting the public health aspects of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreed at the 2001 WTO ministerial conference in Doha, Qatar was considered a milestone in ensuring greater access to medicines for all.
WHO Advisory Group On Pandemic Flu To Meet Next Week
An advisory group on the new World Health Organization framework agreement on pandemic influenza preparedness is preparing to meet for the first time from 21-23 November.
WTO Ministers Asked To Send Message On TRIPS Extension For LDCs
The smallest countries in the World Trade Organization may get more time to comply with the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) after an agreement today.
WTO, WHO, WIPO To Discuss TRIPS And Health Declaration
The heads of three international organizations in Geneva will address a meeting next week on the subject of 10 years after the Doha Declaration on TRIPS and Public Health. The 23 November symposium at the Graduate Institute in Geneva involves a range of top officials and experts on the issue.
Global Action To Open Generic Competition For Key AIDS Drug
Public health advocates in a dozen countries worldwide have launched a coordinated campaign to bring about generic competition on a key medicine for HIV/AIDS, currently under patent by a pharmaceutical producer.
CBO: Generics Bill Would Save US $4.8 Billion
The US Congressional Budget Office has estimated that a current bill to prevent brand-name pharmaceutical companies from paying generic producers to delay the release of generic drugs into the market could save the US budget some $4.8 billion over 10…
Medicines Patent Pool Responds To Critics Of Gilead Licence
The Medicines Patent Pool, which aims to increase access to affordable, high-quality medicines for HIV/AIDS patients in low and middle income countries, has issued a response to concerns about its recent deal with a large pharmaceutical company.